Cell therapy company Mesoblast (ASX:MSB) has entered into a convertible note subscription agreement with its largest shareholder, Gregory George, to issue up to US$50 million convertible notes at its ...
The Business Investment Financing Track (BIFT), a new window within the Global Agriculture and Food Security Program (GAFSP), aims to bolster inclusive, climate-smart, and nutritious food systems in ...
SAN ANTONIO (October 1, 2024) – A therapy showing promise to help control tuberculosis (TB) does not interfere with combined ...